Home > Insider Trading > Filing (0001104659-20-115702)

Filing Details

Accession Number:: 0001104659-20-115702
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-16 17:38:20
Reporting Period:: 2020-10-08

Accepted Time:: 2020-10-16 17:38:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609550	Inspire Medical Systems Inc.	INSP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1199894	C Marilyn Nelson	C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-08-13	5,500	$0.00	171,017	No	5	G	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	4,598	$129.20	166,419	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	7,979	$130.09	158,440	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	6,456	$131.05	151,984	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	2,633	$131.76	149,351	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	600	$132.77	148,751	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	200	$133.81	148,551	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-08	2,534	$135.17	146,017	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2020-10-09	1,000	$130.00	145,017	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,189	Direct

Footnotes

Shares held by GDN Holdings, LLC, of which the Reporting Person is the managing member.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.51 to $129.50. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.54 to $130.53. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.54 to $131.52. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.58 to $132.11. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.66 to $132.98. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.80 to $133.82. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.16 to $135.20. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.